Wave Life Sciences (NASDAQ:WVE) said Takeda (NYSE:TAK) has elected not to exercise its option to further develop its Huntington’s disease treatment candidate WVE-003. As a result, Wave (WVE) is now ...
Company announces successful flight of the latest version of its J-1 wave engine powered UAVs in collaboration with the Department of Defense The North American Wave Engine Corporation (“Wave Engine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results